Progress in drug delivery to the central nervous system by the prodrug approach.

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Barbara PavanSilvia Vertuani

Abstract

This review describes specific strategies for targeting to the central nervous system (CNS). Systemically administered drugs can reach the brain by crossing one of two physiological barriers resistant to free diffusion of most molecules from blood to CNS: the endothelial blood-brain barrier or the epithelial blood-cerebrospinal fluid barrier. These tissues constitute both transport and enzymatic barriers. The most common strategy for designing effective prodrugs relies on the increase of parent drug lipophilicity. However, increasing lipophilicity without a concomitant increase in rate and selectivity of prodrug bioconversion in the brain will result in failure. In these regards, consideration of the enzymes present in brain tissue and in the barriers is essential for a successful approach. Nasal administration of lipophilic prodrugs can be a promising alternative non-invasive route to improve brain targeting of the parent drugs due to fast absorption and rapid onset of drug action. The carrier-mediated absorption of drugs and prodrugs across epithelial and endothelial barriers is emerging as another novel trend in biotherapeutics. Several specific transporters have been identified in boundary tissues between blood and CNS comp...Continue Reading

References

Jul 1, 1979·The Journal of Clinical Investigation·W M Pardridge, L J Mietus
Oct 26, 1979·European Journal of Pharmacology·R W HortonB S Meldrum
Mar 25, 1975·Biochimica Et Biophysica Acta·W M Pardridge, W H Oldendorf
Dec 1, 1975·Journal of Neurochemistry·P Krogsgaard-Larsen, G A Johnston
Jun 26, 1992·Journal of Medicinal Chemistry·M C Fournié-ZaluskiB P Roques
Jan 1, 1991·Comparative Biochemistry and Physiology. A, Comparative Physiology·R C Rose, A M Bode
Jan 1, 1989·Pharmacology & Therapeutics·B Oberg
May 1, 1988·Neuropharmacology·C N HinkoJ D Wood
May 1, 1986·Journal of Neurochemistry·A FuglsangA Gjedde
Mar 18, 1969·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·J M Diamond, E M Wright
Dec 1, 1971·The American Journal of Physiology·W H Oldendorf
Oct 1, 1983·Physiological Reviews·W M Pardridge
Nov 25, 1994·Journal of Medicinal Chemistry·P D Leeson, L L Iversen
Jul 19, 1994·Proceedings of the National Academy of Sciences of the United States of America·R PoltV J Hruby
Oct 19, 1993·European Journal of Pharmacology·D M LambertP Dumont
Feb 4, 1994·Journal of Medicinal Chemistry·F G SalituroR Schwarcz
Nov 22, 1996·Journal of Medicinal Chemistry·K Prokai-TatraiN Bodor
Sep 28, 1998·Journal of Medicinal Chemistry·P ChenL Prokai
Oct 10, 1998·The Journal of Membrane Biology·H FischerA Seelig
Feb 9, 1999·Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progrès Des Recherches Pharmaceutiques·L Prokai
Apr 15, 1999·Nature Medicine·B Gilchrest
May 7, 1999·Journal of Pharmaceutical Sciences·F P BoninaP de Caprariis
May 20, 1999·Nature·H TsukaguchiM A Hediger
Jun 17, 1999·Nature Medicine·P A Friedman, M L Zeidel
Sep 2, 1999·Biochemical and Biophysical Research Communications·D P RajanP D Prasad
Apr 27, 2000·Trends in Neurosciences·M E Rice
Jul 13, 2000·Journal of Medicinal Chemistry·E J BilskyR Polt

❮ Previous
Next ❯

Citations

Apr 8, 2010·Pharmaceutical Research·Yin Cheong Wong, Zhong Zuo
Jan 10, 2013·Molecular Therapy. Nucleic Acids·Congsheng ChengBeverly L Davidson
Dec 19, 2012·International Journal of Molecular Sciences·Amjad M Qandil
Oct 1, 2010·Therapeutic Delivery·V Mangas-SanjuanM Bermejo
Dec 19, 2009·Expert Opinion on Drug Delivery·Santosh Pasha, Kshitij Gupta
Jan 26, 2010·Expert Opinion on Drug Delivery·Yunjin Jung, Young Mi Kim
Oct 26, 2011·Journal of Drug Targeting·Mohammad FazilJaved Ali
Apr 13, 2012·Expert Opinion on Drug Discovery·Piera SozioAntonio Di Stefano
Apr 1, 2011·Journal of Pharmaceutical Sciences·Elisabetta GaviniAlessandro Dalpiaz
Sep 17, 2010·Journal of Pharmaceutical Sciences·Alessandro DalpiazSanto Scalia
Dec 6, 2011·Advanced Drug Delivery Reviews·Devaiah VytlaJames J Chambers
Feb 15, 2011·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Kuo-Sheng LiuJia-You Fang
May 26, 2010·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·M Intakhab AlamM Akbar
Jul 14, 2009·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Jhi-Joung WangJia-You Fang
Apr 28, 2009·Progress in Neurobiology·Ivona BrasnjevicUNKNOWN European NanoBioPharmaceutics Research Initiative
Nov 15, 2008·Peptides·Xiao-Mei WanLong-Ping Wen
Mar 22, 2012·Medicinal Research Reviews·Patrick Vlieghe, Michel Khrestchatisky
Nov 27, 2010·Archiv der Pharmazie·Sheha Mahmoud, Alhawi Mohammad
Dec 12, 2013·Chemical Biology & Drug Design·Jocelyn StockwellChangiz Taghibiglou
Jun 19, 2012·European Journal of Medicinal Chemistry·Silvia VertuaniAlessandro Dalpiaz
Dec 21, 2016·Journal of the American Chemical Society·Asif ShajahanSrinivasa-Gopalan Sampathkumar
Feb 24, 2018·Chembiochem : a European Journal of Chemical Biology·Alexander P GorkaMartin J Schnermann
Jun 25, 2019·Central Nervous System Agents in Medicinal Chemistry·Saganuwan Alhaji Saganuwan
Apr 25, 2020·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Soumen SahaArabinda Chaudhuri
Apr 24, 2020·Current Pharmaceutical Design·Anmol DograJasjeet K Narang
Jan 25, 2018·Expert Opinion on Drug Discovery·Ivana CacciatoreAntonio Di Stefano
Nov 6, 2018·Genes·Carla Lucia EspositoVittorio de Franciscis
Jan 17, 2020·Pharmaceutics·Marco CavacoVera Neves
Nov 25, 2018·Toxins·José Luiz LiberatoWagner Ferreira Dos Santos
Aug 23, 2020·International Journal of Molecular Sciences·Cecilia T de BarrosMarco V Chaud
Apr 16, 2020·Current Drug Delivery·Behrang Shiri VarnamkhastiAli Akbar Saboury

❮ Previous
Next ❯

Methods Mentioned

BETA
lipidation
deamination

Related Concepts

Related Feeds

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood-Brain Barrier Transport in Neurodegeneration

The blood brain barrier is important for regulating the movement of biomolecules in and out of the brain. For example, membrane transporters in the blood brain barrier can be essential for regulating drug movement and dysregulation of these processes may play a role in neurodegeneration. This feed follows the latest research on this topic.